摘要:
The pharmaceutical preparation comprising colforsin dapropate hydrochloride and an alkali metal halide is the oral preparation with excellent storage stability.
摘要:
This invention relates to a process for the preparation of a 6,7-diacyl-7-deacetylforskolin derivative represented by the general formula: ##STR1## wherein R.sup.1 and R.sup.2 each stands for an acyl group and R.sup.3 stands for an aliphatic group having 2 to 3 carbon atoms, which comprises eliminating the acyl group at position 1 in a 1,6,7-triacyl-7-deacetylforskolin derivative represented by the general formula: ##STR2## wherein R.sup.1, R.sup.2 and R.sup.3 are as defined above, by solvolysis. The compound of the formula (I) is expected as medicine.
摘要翻译:本发明涉及一种制备由以下通式表示的6,7-二酰基-7-脱乙酰福斯克林衍生物的方法:(*化学结构*)(I)其中R1和R2各自代表酰基,R3代表 具有2至3个碳原子的脂族基团,其包括通过以下通式除去在通式为(* CHEMICAL STRUCTURE *)(III)表示的1,6,7-三酰基-7-脱乙酰福斯克林衍生物中的第1位的酰基,其中R1 ,R2和R3如上定义,通过溶剂分解。 预期式(I)化合物为药物。
摘要:
This invention relates to a process for the preparation of a 6,7-diacyl-7-deacetylforskolin derivative represented by the general formula: ##STR1## wherein R.sup.1 and R.sup.2 each stands for an acyl group and R.sup.3 stands for an aliphatic group having 2 to 3 carbon atoms, which comprises eliminating the acyl group at position 1 in a 1,6,7-triacyl-7-deacetylforskolin derivative represented by the general formula: ##STR2## wherein R.sup.1, R.sup.2 and R.sup.3 are as defined above, by solvolysis. The compound of the formula (I) is expected as medicine.